HB 2545 Pennsylvania House · 2025-2026 Regular Session

An Act providing for insurance coverage for vaginal estrogen for the treatment of menopausal symptoms and urinary tract infections.

This Pennsylvania bill requires most health insurance plans to cover vaginal estrogen when used to treat menopausal symptoms or prevent urinary tract infections. The law mandates that insurers include FDA-approved drugs, devices, and combination products for this treatment, though they may still apply standard rules regarding medical necessity and patient cost-sharing. Coverage applies to new or renewed policies starting 90 days after the bill takes effect, with specific timelines for plans that do not need to file rates or forms with the state.
Bill status in committee 3 of 5 stages cleared
Introduction
May 2026
Committee Review
Jun 2026
House Passage
Jun 2026
Senate Passage
Governor
Introduced May 27, 2026 Last action Jun 24, 2026
Floor votes · House Jun 24, 2026

How they voted

260
Passed
Total votes 26
Jun 24, 2026
D Democratic14
14 Yea
100% Yea
R Republican12
12 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
4
Key actions
2
Committee
3
Jun 24, 2026
House · Passed
House Vote: pass (26-0)
house
Jun 24, 2026
Committee
Re-referred to Aging & Older Adult Services
lower
Jun 24, 2026
Lower · Passed
Reported with request to re-refer to Aging & Older Adult Services
lower
May 27, 2026
Committee
Referred to Insurance
lower
1 primary · 4 co-sponsors

Sponsors